CClinicalTrials.gg
Not yet recruitingNCT07745985Updated Aug 4, 2026

Early Detection of Ulnar Sparing After Supraclavicular Block Using Infrared Thermography and Perfusion Index

An observational study in Elective Upper Limb Surgery Distal to the Elbow, sponsored by Fayoum University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Fayoum University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
92
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Aim of the Study The aim of this study is to evaluate the effectiveness of early temperature changes measured by infrared thermography and perfusion index monitoring in predicting ulnar nerve sparing following ultrasound-guided supraclavicular brachial plexus block.

Patients and Methods Study Design This study will be a prospective observational diagnostic accuracy study conducted at the Department of Anesthesia, Surgical ICUS \&Pain Management in Fayoum University Hospital. The researcher will inform the participants about the objectives of the study, the examination, and the investigation that will be done. Also, the confidentiality of their information and their right not to participate in the study. Written informed consent will be obtained from all patients included in the study.

Study Population Adult patients scheduled for elective upper limb surgery distal to the elbow under ultrasound-guided supraclavicular brachial plexus block.

Inclusion Criteria

  1. Adult patients aged 18-65 years.
  2. American Society of Anesthesiologists (ASA) physical status I-II.
  3. Scheduled for elective unilateral upper limb surgery. Exclusion Criteria

1. Peripheral neuropathy 2. Raynaud's disease or peripheral vascular disease 3. Diabetes mellitus with neuropathy 4. Infection at injection site 5. Allergy to local anesthetics 6. BMI > 35 kg/m² 7. Preexisting temperature asymmetry between limbs Interventions Ninty-two patients will receive ultrasound-guided supraclavicular brachial plexus block using a high-frequency linear probe. A standardized volume (30 mL) of local anesthetic mixture will be injected using in-plane technique. The block will be performed by experienced anesthesiologists.

Measurements Baseline

  • Skin temperature at:

    • Tip of the little finger (ulnar nerve territory)
    • Tip of index finger (median nerve territory)
    • Dorsal base of index finger (radial nerve territory)
  • Perfusion index at corresponding digits Post-block Assessments Temperature and PI measurements will be recorded at the baseline, every 1 min for the first 10 min after local anesthetic injection, and then every 3 min in the following 21 min.

Temperature will be measured using a calibrated infrared thermographic camera under standardized ambient conditions (room temperature controlled, no external heat sources).

Perfusion index will be recorded using a pulse oximeter probe placed on the finger.

The Perfusion Index Ratio (PIR) is defined as the ratio of the perfusion index measured after an intervention to the baseline perfusion index:

Clinical Block Assessment

Sensory block will be assessed every 5 minutes using cold sensation and pinprick testing in the dermatomal distribution of:

  • Ulnar nerve
  • Median nerve
  • Radial nerve
  • Musculocutaneous nerve Block will be considered successful if complete sensory loss occurs within 30 minutes. Ulnar sparing will be defined as preserved sensation in ulnar territory requiring supplemental anesthesia.

Patients with overlapping failure in other nerve territories will be excluded from isolated ulnar sparing analysis when evaluating segment-specific outcomes.

Outcomes Primary Outcome The ability of perfusion index ratio and temperature changes at little fingers for predicting ulnar nerve sparing at 5 mins.

Secondary Outcomes

  • The ability of perfusion index ratio and temperature changes at little fingers for predicting ulnar nerve sparing along with other time trends, in the first 30 mins.
  • Time needed to reach maximum perfusion index ratio and maximum temperature changes in cases of successful brachial plexus block and in cases of ulnar spared block.
  • Sensitivity, specificity, positive predictive value, and negative predictive value.
  • Receiver operating characteristic (ROC) curve analysis. Sample size calculation The sample size was determined based on the methodology for comparing the area under the receiver operating characteristic (ROC) curve (AUC), using MedCalc Statistical Software (version 23; MedCalc Software, Belgium). An expected AUC of 0.92 was assumed for infrared thermography, as reported by Gamal et al. (2023). The minimum clinically acceptable AUC was set at 0.79, representing the lower bound of diagnostic performance reported for the perfusion index [4,5].

A two-sided type I error rate (α) of 0.05 and a type II error rate (β) of 0.20 (corresponding to 80% power) were specified. The ratio of positive to negative cases was set at 0.194, assuming an an anticipated ulnar sparing prevalence of 16% reported in the literature (Gamal et al., 2023). Based on these assumptions, the required sample size was calculated to be 77 patients in the successful block group and 15 patients in the ulnar sparing group, yielding a total sample size of 92 patients.

02

Conditions studied

  • Elective Upper Limb Surgery Distal to the Elbow

Keywords

  • supraclavicular brachial plexus block
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients scheduled for elective upper limb surgery distal to the elbow under ultrasound-guided supraclavicular brachial plexus block.

Inclusion criteria

  1. Adult patients aged 18-65 years.
  2. American Society of Anesthesiologists (ASA) physical status I-II.
  3. Scheduled for elective unilateral upper limb surgery.

Exclusion criteria

Exclusion Criteria:

  1. Peripheral neuropathy
  2. Raynaud's disease or peripheral vascular disease
  3. Diabetes mellitus with neuropathy
  4. Infection at injection site
  5. Allergy to local anesthetics
  6. BMI > 35 kg/m²
  7. Preexisting temperature asymmetry between limbs
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
92 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Ninety-two patients will receive an ultrasound-guided supraclavicular brachial plexus block using a

    Adult patients scheduled for elective upper limb surgery distal to the elbow under ultrasound-guided supraclavicular brachial plexus block.

    Procedure: Supraclavicular Block

Interventions

  • ProcedureSupraclavicular Block

    Ninety-two patients will receive an ultrasound-guided supraclavicular brachial plexus block using a high-frequency linear probe. A standardized volume (30 mL) of local anesthetic mixture will be injected using the in-plane technique. The block will be performed by experienced anesthesiologists.

05

What researchers measure

Primary outcomes

  1. Perfusion index ratio at the little finger

    Change in the perfusion index ratio measured at the little finger 5 minutes after the intervention. The perfusion index ratio will be evaluated for its ability to predict ulnar nerve sparing

    Time frame: 5 minutes

  2. Temperature change at the little finger

    Temperature change (°C) measured at the little finger 5 minutes after block performance.

    Time frame: 5 minutes

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07745985
Lead sponsor
Fayoum University
Collaborators
Fayoum University Hospital
Responsible party
Mohamed Ahmed Hamed (Professor, Fayoum University) — Principal investigator
First posted
Aug 4, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Jul 20, 2027 (estimated)
Completion
Jul 20, 2027 (estimated)
Last update
Aug 4, 2026

Study contacts

Ahmed Tarek Abd El Azim, MCs
Contact
AHMEDTAHA42000@GMAIL.COM
+20 10 67535636

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion